These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 15364690)

  • 1. APOE and APOC1 promoter polymorphisms and the risk of Alzheimer disease in African American and Caribbean Hispanic individuals.
    Tycko B; Lee JH; Ciappa A; Saxena A; Li CM; Feng L; Arriaga A; Stern Y; Lantigua R; Shachter N; Mayeux R
    Arch Neurol; 2004 Sep; 61(9):1434-9. PubMed ID: 15364690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The algorithm for Alzheimer risk assessment based on APOE promoter polymorphisms.
    Limon-Sztencel A; Lipska-Ziętkiewicz BS; Chmara M; Wasag B; Bidzan L; Godlewska BR; Limon J
    Alzheimers Res Ther; 2016 May; 8(1):19. PubMed ID: 27193889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics.
    Tang MX; Stern Y; Marder K; Bell K; Gurland B; Lantigua R; Andrews H; Feng L; Tycko B; Mayeux R
    JAMA; 1998 Mar; 279(10):751-5. PubMed ID: 9508150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.
    Farrer LA; Cupples LA; Haines JL; Hyman B; Kukull WA; Mayeux R; Myers RH; Pericak-Vance MA; Risch N; van Duijn CM
    JAMA; 1997 Oct 22-29; 278(16):1349-56. PubMed ID: 9343467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter polymorphism (-491A/T) in the APOE gene of Finnish Alzheimer's disease patients and control individuals.
    Helisalmi S; Hiltunen M; Valonen P; Mannermaa A; Koivisto AM; Lehtovirta M; Ryynänen M; Soininen H
    J Neurol; 1999 Sep; 246(9):821-4. PubMed ID: 10525981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between APOC1 polymorphism and Alzheimer's disease: a case-control study and meta-analysis.
    Zhou Q; Zhao F; Lv ZP; Zheng CG; Zheng WD; Sun L; Wang NN; Pang S; de Andrade FM; Fu M; He XH; Hui J; Jiang W; Yang CY; Shi XH; Zhu XQ; Pang GF; Yang YG; Xie HQ; Zhang WD; Hu CY; Yang Z
    PLoS One; 2014; 9(1):e87017. PubMed ID: 24498013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between selected cholesterol-related gene polymorphisms and Alzheimer's disease in a Turkish cohort.
    Guven G; Vurgun E; Bilgic B; Hanagasi H; Gurvit H; Ozer E; Lohmann E; Erginel-Unaltuna N
    Mol Biol Rep; 2019 Apr; 46(2):1701-1707. PubMed ID: 30684189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E promoter polymorphisms (-491A/T and -427T/C) and Alzheimer's disease: no evidence of association in the Irish population.
    Lynch CA; Brazil J; Cullen B; Coakley D; Gill M; Lawlor BA; Hawi Z
    Ir J Med Sci; 2008 Mar; 177(1):29-33. PubMed ID: 18057979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The -491A/T apolipoprotein E promoter polymorphism association with Alzheimer's disease: independent risk and linkage disequilibrium with the known APOE polymorphism.
    Town T; Paris D; Fallin D; Duara R; Barker W; Gold M; Crawford F; Mullan M
    Neurosci Lett; 1998 Aug; 252(2):95-8. PubMed ID: 9756330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease.
    Lambert JC; Berr C; Pasquier F; Delacourte A; Frigard B; Cottel D; Pérez-Tur J; Mouroux V; Mohr M; Cécyre D; Galasko D; Lendon C; Poirier J; Hardy J; Mann D; Amouyel P; Chartier-Harlin MC
    Hum Mol Genet; 1998 Sep; 7(9):1511-6. PubMed ID: 9700208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein E -491 promoter polymorphism is an independent risk factor for Alzheimer's disease in the Chinese population.
    Yang JD; Feng GY; Zhang J; Cheung J; St Clair D; He L; Ichimura K
    Neurosci Lett; 2003 Oct; 350(1):25-8. PubMed ID: 12962909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of association of 13 polymorphisms in eight genes in southeastern African American Alzheimer disease patients as compared to age-matched controls.
    Perry RT; Collins JS; Harrell LE; Acton RT; Go RC
    Am J Med Genet; 2001 May; 105(4):332-42. PubMed ID: 11378846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ApoE -491A/T promoter polymorphism is not an independent risk factor, but associated with the epsilon4 allele in Hungarian Alzheimer's dementia population.
    Juhász A; Palotás A; Janka Z; Rimanóczy A; Palotás M; Bódi N; Boda K; Zana M; Vincze G; Kálmán J
    Neurochem Res; 2005 May; 30(5):591-6. PubMed ID: 16176061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of APOE promoter polymorphisms to Alzheimer's disease risk.
    Lambert JC; Araria-Goumidi L; Myllykangas L; Ellis C; Wang JC; Bullido MJ; Harris JM; Artiga MJ; Hernandez D; Kwon JM; Frigard B; Petersen RC; Cumming AM; Pasquier F; Sastre I; Tienari PJ; Frank A; Sulkava R; Morris JC; St Clair D; Mann DM; Wavrant-DeVrièze F; Ezquerra-Trabalon M; Amouyel P; Hardy J; Haltia M; Valdivieso F; Goate AM; Pérez-Tur J; Lendon CL; Chartier-Harlin MC
    Neurology; 2002 Jul; 59(1):59-66. PubMed ID: 12105308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Th1/E47cs-G apolipoprotein E (APOE) promoter allele is a risk factor for Alzheimer disease of very later onset.
    Beyer K; Lao JI; Gómez M; Riutort N; Latorre P; Mate JL; Ariza A
    Neurosci Lett; 2002 Jul; 326(3):187-90. PubMed ID: 12095653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of independent associations of apolipoprotein E promoter and intron 1 polymorphisms with Alzheimer's disease.
    Rebeck GW; Cheung BS; Growdon WB; Deng A; Akuthota P; Locascio J; Greenberg SM; Hyman BT
    Neurosci Lett; 1999 Sep; 272(3):155-8. PubMed ID: 10505604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic association of an apolipoprotein C-I (APOC1) gene polymorphism with late-onset Alzheimer's disease.
    Ki CS; Na DL; Kim DK; Kim HJ; Kim JW
    Neurosci Lett; 2002 Feb; 319(2):75-8. PubMed ID: 11825674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allelic expression of APOE in human brain: effects of epsilon status and promoter haplotypes.
    Bray NJ; Jehu L; Moskvina V; Buxbaum JD; Dracheva S; Haroutunian V; Williams J; Buckland PR; Owen MJ; O'Donovan MC
    Hum Mol Genet; 2004 Nov; 13(22):2885-92. PubMed ID: 15385439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic association study between senile dementia of Alzheimer's type and APOE/C1/C2 gene cluster.
    Kamino K; Yoshiiwa A; Nishiwaki Y; Nagano K; Yamamoto H; Kobayashi T; Nonomura Y; Yoneda H; Sakai T; Imagawa M; Miki T; Ogihara T
    Gerontology; 1996; 42 Suppl 1():12-9. PubMed ID: 8804993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk for Alzheimer's disease correlates with transcriptional activity of the APOE gene.
    Artiga MJ; Bullido MJ; Frank A; Sastre I; Recuero M; García MA; Lendon CL; Han SW; Morris JC; Vázquez J; Goate A; Valdivieso F
    Hum Mol Genet; 1998 Nov; 7(12):1887-92. PubMed ID: 9811931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.